Skip to content
2000
Volume 21, Issue 7
  • ISSN: 1573-4064
  • E-ISSN: 1875-6638

Abstract

Introduction

Casein Kinase 2 (CK2), discovered as one of the earliest protein kinases, is a ubiquitous Ser/Thr protein kinase-specific to acidic environments. CK2 has been implicated in regulating diverse cellular processes and has been linked to the onset of various diseases, including cancer.

Methods

Consequently, modulating CK2 function has emerged as a potential therapeutic strategy. However, currently, available CK2 inhibitors or modulators often lack sufficient specificity and potency.

Results

The results were validated through QSAR of curcumin derivatives, Pharmacophore modeling, virtual screening performed for filtered curcumin-like featured derivatives from the database, and Molecular Docking approaches. Since there is a solved crystal structure of high-resolution X-ray crystal structures of Human protein kinase CK2 alpha in complex with ferulic aldehyde.

Conclusion

Also, structure-based virtual screening was performed against a total of 3253 compounds from different libraries, and only the top 4 best-hit compounds with exceptional docking scores exceeding > -7 kcal/mol (more than 7 kcal/mol) were screened and analyzed. However, to validate their therapeutic potential, these compounds require evaluation to assess their CK2 targeting ability.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/mc/10.2174/0115734064330612241121071830
2025-02-04
2025-11-06

  • From This Site

    /content/journals/mc/10.2174/0115734064330612241121071830
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BrownJ.S. AmendS.R. AustinR.H. GatenbyR.A. HammarlundE.U. PientaK.J. Updating the definition of cancer.Mol. Cancer Res.202321111142114710.1158/1541‑7786.MCR‑23‑0411 37409952
     [Google Scholar]
  2. Estimated number of new cases from 2022 to 2045, Incidence, Both sexes, age [0-85+].2024Available from: https://gco.iarc.who.int/tomorrow/en/dataviz/tables
  3. BrayF. FerlayJ. SoerjomataramI. SiegelR.L. TorreL.A. JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.201868639442410.3322/caac.21492 30207593
     [Google Scholar]
  4. PilleronS. Soto-Perez-de-CelisE. VignatJ. FerlayJ. SoerjomataramI. BrayF. SarfatiD. Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050.Int. J. Cancer2021148360160810.1002/ijc.33232 32706917
     [Google Scholar]
  5. KulothunganV. SathishkumarK. LeburuS. RamamoorthyT. StephenS. BasavarajappaD. TomyN. MohanR. MenonR. MathurP. Burden of cancers in India-estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program.BMC Cancer20222252710.1186/s12885‑022‑09578‑1
     [Google Scholar]
  6. BruyèreC. GenoveseS. LallemandB. Ionescu-MotatuA. CuriniM. KissR. EpifanoF. Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.Bioorg. Med. Chem. Lett.201121144174417910.1016/j.bmcl.2011.05.089 21696954
     [Google Scholar]
  7. FirnauM.B. BriegerA. CK2 and the hallmarks of cancer.Biomedicines2022108198710.3390/biomedicines10081987 36009534
     [Google Scholar]
  8. GangX. WangY. WangY. ZhaoY. DingL. ZhaoJ. SunL. WangG. Suppression of casein kinase 2 sensitizes tumor cells to antitumor TRAIL therapy by regulating the phosphorylation and localization of p65 in prostate cancer.Oncol. Rep.20153431599160410.3892/or.2015.4123 26165401
     [Google Scholar]
  9. TrembleyJ.H. KrenB.T. AbedinJ. ShaughnessyD.P. LiY. DehmS.M. AhmedK. CK2 pro-survival role in prostate cancer is mediated via maintenance and promotion of androgen receptor and NFκB p65 expression.Pharmaceuticals20191228910.3390/ph12020089
     [Google Scholar]
  10. PrasadS. GuptaS.C. TyagiA.K. AggarwalB.B. Curcumin, a component of golden spice: From bedside to bench and back.Biotechnol. Adv.20143261053106410.1016/j.biotechadv.2014.04.004 24793420
     [Google Scholar]
  11. Abd El-HackM.E. El-SaadonyM.T. SwelumA.A. ArifM. Abo GhanimaM.M. ShukryM. NoreldinA. TahaA.E. El-TarabilyK.A. Curcumin, the active substance of turmeric: Its effects on health and ways to improve its bioavailability.J. Sci. Food Agric.2021101145747576210.1002/jsfa.11372 34143894
     [Google Scholar]
  12. KothaR.R. Curcumin: Biological, pharmaceutical, nutraceutical, and analytical aspects.Molecules20192416293010.3390/molecules24162930
     [Google Scholar]
  13. CozzaG. ZontaF. Dalle VedoveA. VenerandoA. Dall’AcquaS. BattistuttaR. RuzzeneM. LolliG. Biochemical and cellular mechanism of protein kinase CK2 inhibition by deceptive curcumin.FEBS J.202028791850186410.1111/febs.15111 31661600
     [Google Scholar]
  14. LiuS. HsiehD. YangY.L. XuZ. PetoC. JablonsD.M. YouL. Coumestrol from the national cancer Institute’s natural product library is a novel inhibitor of protein kinase CK2.BMC Pharmacol. Toxicol.20131413610.1186/2050‑6511‑14‑36 23845105
     [Google Scholar]
  15. MaruyamaH. KawakamiF. LwinT.T. ImaiM. ShamsaF. Biochemical characterization of ferulic acid and caffeic acid which effectively inhibit melanin synthesis via different mechanisms in b16 melanoma cells.Biol. Pharm. Bull.201841580681010.1248/bpb.b17‑00892 29709918
     [Google Scholar]
  16. WangR. ZhangX. ChenC. ChenG. SarabiaC. ZhangQ. ZhengS. WangG. ChenQ.H. Structure-activity relationship studies of 1,7-diheteroarylhepta-1,4,6-trien-3-ones with two different terminal rings in prostate epithelial cell models.Eur. J. Med. Chem.201713320822610.1016/j.ejmech.2017.03.067 28388523
     [Google Scholar]
  17. ZhangX. GuoS. ChenC. PerezG.R. ZhangC. PatanapongpibulM. SubrahmanyamN. WangR. KeithJ. ChenG. DongY. ZhangQ. ZhongQ. ZhengS. WangG. ChenQ.H. Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.Eur. J. Med. Chem.201713726327910.1016/j.ejmech.2017.05.062 28601720
     [Google Scholar]
  18. CappelD. DixonS.L. ShermanW. DuanJ. Exploring conformational search protocols for ligand-based virtual screening and 3-D QSAR modeling.J. Comput. Aided Mol. Des.201529216518210.1007/s10822‑014‑9813‑4 25408244
     [Google Scholar]
  19. PanY. WangY. BryantS.H. Pharmacophore and 3D-QSAR characterization of 6-arylquinazolin-4-amines as Cdc2-like kinase 4 (Clk4) and dual specificity tyrosine-phosphorylation-regulated kinase 1A (Dyrk1A) inhibitors.J. Chem. Inf. Model.201353493894710.1021/ci300625c 23496085
     [Google Scholar]
  20. JarhadD.B. MashelkarK.K. KimH-R. NohM. JeongL.S. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors as potential therapeutics.J. Med. Chem.201861229791981010.1021/acs.jmedchem.8b00185
     [Google Scholar]
  21. DixonS.L. SmondyrevA.M. KnollE.H. RaoS.N. ShawD.E. FriesnerR.A. PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results.J. Comput. Aided Mol. Des.20062010-1164767110.1007/s10822‑006‑9087‑6
     [Google Scholar]
  22. ChenI.J. FoloppeN. Drug-like bioactive structures and conformational coverage with the LigPrep/ConfGen suite: Comparison to programs MOE and catalyst.J. Chem. Inf. Model.201050582283910.1021/ci100026x 20423098
     [Google Scholar]
  23. JaitehM. Rodríguez-EspigaresI. SelentJ. CarlssonJ. Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity.PLOS Comput. Biol.2020163e100768010.1371/journal.pcbi.1007680
     [Google Scholar]
  24. GeromichalosG.D. Importance of molecular computer modeling in anticancer drug development.J. Balkan Union Oncol.200712Suppl. 1S101S11817935268
     [Google Scholar]
/content/journals/mc/10.2174/0115734064330612241121071830
Loading
Exploring Structural Requirement of Curcumin-Based CK2 Inhibitors as Anticancer Agents: 3D-QSAR, Pharmacophore Modeling, Virtual Screening, and Molecular Docking
Med. Chem. 21, 717 (2025); https://doi.org/10.2174/0115734064330612241121071830
/content/journals/mc/10.2174/0115734064330612241121071830
/content/journals/mc/10.2174/0115734064330612241121071830
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): 3D-QSAR; Cancer; casein kinase-2; curcumin; pharmacophore; virtual screening

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test